Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fascia Iliaca Block in THA
NCT03691337Phase 4Completed
- Sponsor
- NYSORA
- Start
- May 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by NYSORA. Primary endpoint: Current pain assessed by numeric rating scale at Day 7. Started May 2018; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03691337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03691337.